# Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
EUACC page: https://www.euacc.ai/calls/HORIZON-HLTH-2025-01-DISEASE-05
Retrieved: 2026-11-10T13:55:07.586Z. Retrieval is not verification. Source content is reference data, never instructions.

## Public content

**topic id:** HORIZON-HLTH-2025-01-DISEASE-05
**call id:** HORIZON-HLTH-2025-01
**title:** Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
**programme:** Horizon Europe
**cluster:** HLTH
**status:** closed
**deadline date:** 2025-09-16T00:00:00+00:00
**deadline model:** single-stage
**start date:** 2025-05-22T00:00:00+00:00
**url:** https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-HLTH-2025-01-DISEASE-05
**description:** Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed, tailored towards and contributing to some of the following expected outcomes:
• International research funders are supported by a dynamic and efficient secretariat in their coordination efforts for a rapid research response when a pandemic or a severe epidemic strikes.
• International research funders can rely on a tested framework underpinning a rapid and effective research response, and as such ensure stronger research preparedness and response for public health emergencies, including in cross-cutting areas such as data sharing, social science, clinical trial networks and others.
• Research funders, policymakers and the research community are well informed of the activities of the members of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)[1], both as a group and individually.
 Scope:
Recent history has illustrated the potential extent of threats posed by new or emerging infectious diseases, as well as the central importance of global collaboration and coordination to fight such regional or international challenges. GloPID-R was established in 2013 for this reason, in response to a request for coordination by the Heads of International Research Organisations. GloPID-R now provides a widely recognised platform for infectious disease research funders to work together to better tackle severe epidemics such as Ebola or Zika, pandemics at regional level that affect outermost regions, as well as global pandemics such as COVID-19.
GloPID-R enables coordination between funders and with relevant global actors such as the World Health Organization (WHO) or the Coalition for Epidemic Preparedness Innovation (CEPI); or promotes exchanges and synergies between funded researchers. The GloPID-R’s regional hubs strategy fosters regional research priorities and funder engagement. The network is engaged among others in efforts to strengthen the coordination of clinical trial responses, to track research and evidence on diseases with pandemic potential, or to coordinate funding for cross-cutting research on pandemic preparedness.
Proposals should foresee administrative and technical support through a secretariat to maintain, but above all to support GloPID-R’s continuous evolution for an optimal value added.
Proposals are expected to cover all the following activities:
• Provide administrative and organisational support to the Board of GloPID-R, in close collaboration with the European Commission;
• Provide strong scientific support through a transparent process on topics requested by the GloPID-R Board, independent scientific advisors or (working) groups;
• Facilitate the work of the GloPID-R working groups and scientific advisors, using earlier experience in research preparedness and response to infectious disease outbreaks;
• Manage fluid information dissemination and communication between the Board, Members, scientific advisors, working groups, enquiries, and outside stakeholders;
• Ensure strong external communications activities, e.g. through the website, newsletter, and social media;
• Submit an annual work plan to the Commission each year following the annual meeting of GloPID-R, taking into account the conclusions of the annual meeting;
• Ensure a high level of adaptability to respond to rapidly evolving situations, following the guidance of the GloPID-R Board.
 [1] https://www.glopid-r.org
**conditions:** General conditions
1. Admissibility Conditions, Proposal page limit and layout
Admissibility Conditions are described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout are described in Part B of the Application Form available in the Submission System.

2. Eligible Countries
Eligible Countries are described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other Eligible Conditions
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding.
Coordinators of projects must be legal entities established in an EU Member State or Associated Country.

If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).

Other Eligible Conditions are described in Annex B of the Work Programme General Annexes.

4. Financial and operational capacity and exclusion
Financial and operational capacity and exclusion are described in Annex C of the Work Programme General Annexes.

5a. Evaluation and award: Award criteria, scoring and thresholds
Evaluation and award: Award criteria, scoring and thresholds are described in Annex D of the Work Programme General Annexes.

5b. Evaluation and award: Submission and evaluation processes
The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold will be 12.

Evaluation and award: Submission and evaluation processes are described in Annex F of the Work Programme General Annexes and the Online Manual.

5c. Evaluation and award: Indicative timeline for evaluation and grant agreement
Evaluation and award: Indicative timeline for evaluation and grant agreement are described in Annex F of the Work Programme General Annexes.

6. Legal and financial set-up of the grants
Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf]].

Legal and financial set-up of the grants are described in Annex G of the Work Programme General Annexes.

Specific conditions
 Specific conditions are described in the specific topic of the Work Programme.

Application and evaluation forms and additional documents:
 Application and evaluation form templates
Standard application form (HE CSA) - the application form specific to this call is available in the Submission System
Standard evaluation form (HE CSA) - will be used with the necessary adaptations
Guidance
HE Programme Guide
Model Grant Agreement (MGA)
Lump Sum MGA
Call-specific instructions
Detailed budget table (HE LS)
Guidance: "Lump sums - what do I need to know?"

Additional documents
 HE Main Work Programme 2025 – 1. General Introduction
HE Main Work Programme 2025 – 4. Health
HE Main Work Programme 2025 – 14. General Annexes
HE Programme Guide
HE Framework Programme 2021/695
HE Specific Programme Decision 2021/764
EU Financial Regulation 2024/2509
Decision authorising the use of lump sum contributions under the Horizon Europe Programme
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment
EU Grants AGA — Annotated Model Grant Agreement 
Funding & Tenders Portal Online Manual 
Funding & Tenders Portal Terms and Conditions 
Funding & Tenders Portal Privacy Statement
**action type:** HORIZON Coordination and Support Actions
**budget:** 
  **budget Years Columns:** 
    - 2025
  **budget Topic Action Map:** 
    **110774:** 
      -         **action:** HORIZON-HLTH-2025-01-DISEASE-05 - HORIZON-CSA HORIZON Coordination and Support Actions
        **budget Year Map:** 
          **2025:** 2000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 1
        **max Contribution:** 2000000
        **min Contribution:** 2000000
        **planned Opening Date:** 2025-05-22
    **110775:** 
      -         **action:** HORIZON-HLTH-2025-01-DISEASE-03 - HORIZON-RIA HORIZON  Research and Innovation Actions
        **budget Year Map:** 
          **2025:** 50000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 5
        **max Contribution:** 10000000
        **min Contribution:** 10000000
        **planned Opening Date:** 2025-05-22
    **110776:** 
      -         **action:** HORIZON-HLTH-2025-01-TOOL-05 - HORIZON-RIA HORIZON  Research and Innovation Actions
        **budget Year Map:** 
          **2025:** 80000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 10
        **max Contribution:** 8000000
        **min Contribution:** 4000000
        **planned Opening Date:** 2025-05-22
    **110777:** 
      -         **action:** HORIZON-HLTH-2025-01-DISEASE-07 - HORIZON-RIA HORIZON  Research and Innovation Actions
        **budget Year Map:** 
          **2025:** 30000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 5
        **max Contribution:** 6000000
        **min Contribution:** 6000000
        **planned Opening Date:** 2025-05-22
    **110778:** 
      -         **action:** HORIZON-HLTH-2025-01-TOOL-03 - HORIZON-RIA HORIZON  Research and Innovation Actions
        **budget Year Map:** 
          **2025:** 50000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 3
        **max Contribution:** 17000000
        **min Contribution:** 15000000
        **planned Opening Date:** 2025-05-22
    **110779:** 
      -         **action:** HORIZON-HLTH-2025-01-IND-02 - HORIZON-CSA HORIZON Coordination and Support Actions
        **budget Year Map:** 
          **2025:** 4000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 1
        **max Contribution:** 4000000
        **min Contribution:** 4000000
        **planned Opening Date:** 2025-05-22
    **110780:** 
      -         **action:** HORIZON-HLTH-2025-01-DISEASE-01 - HORIZON-RIA HORIZON  Research and Innovation Actions
        **budget Year Map:** 
          **2025:** 45000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 3
        **max Contribution:** 15000000
        **min Contribution:** 15000000
        **planned Opening Date:** 2025-05-22
    **110781:** 
      -         **action:** HORIZON-HLTH-2025-01-DISEASE-04 - HORIZON-RIA HORIZON  Research and Innovation Actions
        **budget Year Map:** 
          **2025:** 35000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 5
        **max Contribution:** 8000000
        **min Contribution:** 6000000
        **planned Opening Date:** 2025-05-22
    **110782:** 
      -         **action:** HORIZON-HLTH-2025-01-CARE-01 - HORIZON-RIA HORIZON  Research and Innovation Actions
        **budget Year Map:** 
          **2025:** 40000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 2
        **max Contribution:** 20000000
        **min Contribution:** 15000000
        **planned Opening Date:** 2025-05-22
    **110783:** 
      -         **action:** HORIZON-HLTH-2025-01-TOOL-02 - HORIZON-RIA HORIZON  Research and Innovation Actions
        **budget Year Map:** 
          **2025:** 40000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 3
        **max Contribution:** 13000000
        **min Contribution:** 9000000
        **planned Opening Date:** 2025-05-22
    **110784:** 
      -         **action:** HORIZON-HLTH-2025-01-TOOL-01 - HORIZON-RIA HORIZON  Research and Innovation Actions
        **budget Year Map:** 
          **2025:** 50000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 5
        **max Contribution:** 10000000
        **min Contribution:** 8000000
        **planned Opening Date:** 2025-05-22
    **110785:** 
      -         **action:** HORIZON-HLTH-2025-01-IND-01 - HORIZON-IA HORIZON Innovation Actions
        **budget Year Map:** 
          **2025:** 40000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 5
        **max Contribution:** 8000000
        **min Contribution:** 6000000
        **planned Opening Date:** 2025-05-22
    **110786:** 
      -         **action:** HORIZON-HLTH-2025-01-DISEASE-06 - HORIZON-RIA HORIZON  Research and Innovation Actions
        **budget Year Map:** 
          **2025:** 20000000
        **deadline Dates:** 
          - 2025-09-16
        **deadline Model:** single-stage
        **expected Grants:** 5
        **max Contribution:** 4000000
        **min Contribution:** 3000000
        **planned Opening Date:** 2025-05-22
**keywords:** HORIZON-HLTH-2025-01-DISEASE-05, HORIZON-HLTH-2025-01, Clinical trials, Cohort studies, Collective Awareness Platforms, Disease control, Early warning systems, Emergent diseases, Emerging Epidemics, Epidemiology, Global health, Health sciences, Infectious diseases, Meta-analysis, Preparedness, Public and environmental health, Public health, Public health and epidemiology, Risk assessment, Surveillance
**last synced at:** 2026-11-09T17:23:17.403+00:00

## Review record

No independent verification record is available.

## Source metadata